JA Ledermann
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
Papers in
- Oncology 29
- PARP inhibition in cancer therapy 10
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 5
-
- Ovarian cancer diagnosis and treatment 22
- Co-authors
- David Sebag‐Montefiore (6 shared papers)Helen Meadows (6 shared papers)Rob Glynne‐Jones (4 shared papers)John Northover (4 shared papers)R.D. James (4 shared papers)Susan Wan (3 shared papers)Mark Jitlal (1 shared paper)Rebecca Kristeleit (1 shared paper)
- Journals
- Annals of Oncology (12 papers)British Journal of Cancer (12 papers)European Journal of Cancer (5 papers)Journal of Clinical Oncology (5 papers)International Journal of Gynecological Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
JA Ledermann
66 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 96
- Reproductive Medicine 345
- Oncology 718
- Surgery 616
- Radiology, Nuclear Medicine and Imaging 319
- Pathology and Forensic Medicine 147
Countries citing papers authored by JA Ledermann
This map shows the geographic impact of JA Ledermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Ledermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Ledermann more than expected).
Fields of papers citing papers by JA Ledermann
This network shows the impact of papers produced by JA Ledermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Ledermann. The network helps show where JA Ledermann may publish in the future.
Co-authors
The 25 scholars most cited alongside JA Ledermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 294 | |
| 2 | 2014 | 209 | |
| 3 | 2004 | 156 | |
| 4 | 1994 | 86 | |
| 5 | Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial | 2013 | 79 |
| 6 | 1988 | 71 | |
| 7 | 2014 | 67 | |
| 8 | 2010 | 65 | |
| 9 | 1997 | 62 | |
| 10 | 2009 | 61 | |
| 11 | 1989 | 58 | |
| 12 | 2008 | 51 | |
| 13 | 1991 | 45 | |
| 14 | 2020 | 43 | |
| 15 | Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer | 1999 | 41 |
| 16 | 2011 | 41 | |
| 17 | 2014 | 37 | |
| 18 | 1983 | 36 | |
| 19 | ICON7: A PHASE III RANDOMISED GYNAECOLOGIC CANCER INTERGROUP TRIAL OF CONCURRENT BEVACIZUMAB AND CHEMOTHERAPY FOLLOWED BY MAINTENANCE BEVACIZUMAB, VERSUS CHEMOTHERAPY ALONE IN WOMEN WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN (EOC), PRIMARY PERITONEAL (PPC) OR FALLOPIAN TUBE CANCER (FTC) | 2010 | 35 |
| 20 | 1991 | 33 |
About JA Ledermann
JA Ledermann is a scholar working on Oncology, Reproductive Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), PARP inhibition in cancer therapy (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers), BRCA gene mutations in cancer (6 papers), Colorectal and Anal Carcinomas (5 papers), Lung Cancer Research Studies (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Reproductive Medicine (345 citations), Oncology (718 citations), Surgery (616 citations), Radiology, Nuclear Medicine and Imaging (319 citations) and Pathology and Forensic Medicine (147 citations). JA Ledermann has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include David Sebag‐Montefiore, Helen Meadows, Rob Glynne‐Jones, John Northover, R.D. James, Susan Wan, Mark Jitlal, Rebecca Kristeleit, Anthony Maraveyas and Nicholas Counsell. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.